Mehta, P.; Thummar, V.; Bhavsar, H. Clinical Outcomes of Neoadjuvant Dual HER2 Blockade With pertuzumab/Sigrima and trastuzumab/Vivitra Biosimilars: Real-World Evidence in HER2-Positive Breast Cancer in India. Int J Res Med Sci 2026, 14, 1584-1588.